Skip to main content

Approach to the Diagnosis of Amyloidosis

Abstract

Amyloidosis is heterogeneous group of disorder characterized by extracellular deposition of misfolded insoluble proteinaceous material with cross beta pleated sheet structure leading to organ dysfunction. This disease is rare and indeed heterogeneous, as it may be hereditary (familial amyloidosis), secondary to spectrum of inflammatory conditions (AA amyloidosis) or member of plasma cell neoplasm family (AL amyloidosis). AL amyloidosis is the most common type of amyloid, however, is rarely accompanied by multiple myeloma or other lymphoproliferative disorder. This disparity in its origin and presentation needs to be addressed by exhaustive battery of investigation tools, to arrive at right diagnosis with correct typing. This is of utmost importance in guiding the treating physicians to choose appropriate therapeutic options. This review deals with diagnostic approach to amyloidosis and its various subtypes.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. Sipe JD, Cohen AS (2000) Review: history of the amyloid fibril. J Struct Biol 130(2):88–98

    CAS  Article  Google Scholar 

  2. Leung N, Nasr SH, Sethi S (2012) How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. Blood 120(16):3206–3213

    CAS  Article  Google Scholar 

  3. Mollee P, Renaut P, Gottlieb D, Goodman H (2014) How to diagnose amyloidosis. Intern Med J 44(1):7–17

    CAS  Article  Google Scholar 

  4. Tanskanen M (2013) “Amyloid”—Historical aspects. InTech, Rijeka

    Book  Google Scholar 

  5. Rosenzweig M, Landau H (2011) Light chain (AL) amyloidosis: update on diagnosis and management. J Hematol OncolJ Hematol Oncol 18(4):47

    Article  Google Scholar 

  6. Gertz MA (2016) Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment. Am J Hematol 91(9):947–956

    CAS  Article  Google Scholar 

  7. Kumar V, Abbas AK, Aster JC, Perkins JA (2013) Robbins basic pathology. Elsevier/Saunders, Philadelphia, PA

    Google Scholar 

  8. Puchtler H, Sweat F, Levine M (1962) On the binding of Congo red by amyloid. J Histochem Cytochem 10(3):355–364

    CAS  Article  Google Scholar 

  9. Rajkumar SV (2016) Multiple myeloma: 2016 update on diagnosis, risk-stratification and management. Am J Hematol 91(7):719

    CAS  Article  Google Scholar 

  10. Kebbel A, Röcken C (2006) Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol 30(6):673–683

    Article  Google Scholar 

  11. Schönland SO, Hegenbart U, Bochtler T, Mangatter A, Hansberg M, Ho AD et al (2012) Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients. Blood 119(2):488–493

    Article  Google Scholar 

  12. Fernández de Larrea C, Verga L, Morbini P, Klersy C, Lavatelli F, Foli A et al (2015) A practical approach to the diagnosis of systemic amyloidoses. Blood 125(14):2239–2244

    Article  Google Scholar 

  13. Arbustini E, Verga L, Concardi M, Palladini G, Obici L, Merlini G (2002) Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloid 9(2):108–114

    CAS  Google Scholar 

  14. Vrana JA, Theis JD, Dasari S, Mereuta OM, Dispenzieri A, Zeldenrust SR et al (2014) Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics. Haematologica 99(7):1239–1247

    Article  Google Scholar 

  15. Brambilla F, Lavatelli F, Di Silvestre D, Valentini V, Rossi R, Palladini G et al (2012) Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. Blood 119(8):1844–1847

    CAS  Article  Google Scholar 

  16. Hawkins PN, Lavender JP, Pepys MB (1990) Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med 323(8):508–513

    CAS  Article  Google Scholar 

  17. Gertz MA, Skinner M, Sipe JD, Cohen AS, Kyle RA (1985) Serum amyloid A protein and C-reactive protein in systemic amyloidosis. Clin Exp Rheumatol 3(4):317–320

    CAS  PubMed  Google Scholar 

  18. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ et al (1997) A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 336(17):1202–1207

    CAS  Article  Google Scholar 

  19. Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD et al (2002) Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 346(23):1786–1791

    CAS  Article  Google Scholar 

  20. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos M-V et al (2014) International Myeloma Working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15(12):e538–e548

    Article  Google Scholar 

  21. Bahlis NJ, Lazarus HM (2006) Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted? Bone Marrow Transpl 38(1):7–15

    CAS  Article  Google Scholar 

  22. Rajkumar SV, Gertz MA, Kyle RA (1998) Primary systemic amyloidosis with delayed progression to multiple myeloma. Cancer 82(8):1501–1505

    CAS  Article  Google Scholar 

  23. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN et al (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis, Tours, France, 18–22 April 2004. Am J Hematol 79(4):319–328

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Richa Juneja.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Juneja, R., Pati, H.P. Approach to the Diagnosis of Amyloidosis. Indian J Hematol Blood Transfus 36, 246–253 (2020). https://doi.org/10.1007/s12288-019-01208-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-019-01208-4

Keywords

  • Amyloidosis
  • Proteinaceous
  • Cross beta pleated
  • Multiple myeloma
  • AL amyloid
  • AA amyloid